Alimera Sciences (ALIM) News Today $5.56 +0.02 (+0.36%) (As of 09/6/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period September 6 at 2:11 AM | americanbankingnews.comAlimera Sciences (NASDAQ:ALIM) Receives New Coverage from Analysts at StockNews.comAugust 30, 2024 | americanbankingnews.comAlimera Sciences (NASDAQ:ALIM) Coverage Initiated by Analysts at StockNews.comAugust 29, 2024 | americanbankingnews.comAlimera Sciences (NASDAQ:ALIM) Shares Pass Above 200-Day Moving Average of $4.19August 29, 2024 | marketbeat.comAlimera Sciences (NASDAQ:ALIM) Coverage Initiated at StockNews.comStockNews.com assumed coverage on Alimera Sciences in a research report on Thursday. They issued a "hold" rating on the stock.August 21, 2024 | marketbeat.comAlimera Sciences (NASDAQ:ALIM) Research Coverage Started at StockNews.comStockNews.com started coverage on Alimera Sciences in a research note on Wednesday. They issued a "hold" rating on the stock.August 20, 2024 | businesswire.comALIMERA SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alimera ...August 19, 2024 | marketbeat.comVanguard Group Inc. Grows Stake in Alimera Sciences, Inc. (NASDAQ:ALIM)Vanguard Group Inc. grew its holdings in shares of Alimera Sciences, Inc. (NASDAQ:ALIM - Free Report) by 61.1% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,045,460 shares of the biopharmaceutical company's stock after buying an additional 396,5August 14, 2024 | marketbeat.comDeltec Asset Management LLC Invests $690,000 in Alimera Sciences, Inc. (NASDAQ:ALIM)Deltec Asset Management LLC acquired a new position in Alimera Sciences, Inc. (NASDAQ:ALIM - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 124,169 shares of the biopharmaceutical company's stock, valued aAugust 9, 2024 | msn.comShould You Invest on Alimera Sciences, Inc. (ALIM) Right Now?August 7, 2024 | marketbeat.comAlimera Sciences (NASDAQ:ALIM) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPSAlimera Sciences (NASDAQ:ALIM - Get Free Report) released its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.02). The firm had revenue of $27.00 million during the quarter, compared to analyst estimates of $25.76 million. Alimera Sciences had a negative net margin of 23.74% and a negative return on equity of 53.49%.August 6, 2024 | globenewswire.comAlimera Sciences Reports Second Quarter 2024 ResultsJuly 27, 2024 | globenewswire.comALIM ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc.July 26, 2024 | prnewswire.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc. - ALIMJuly 25, 2024 | finance.yahoo.comInvesting in Alimera Sciences (NASDAQ:ALIM) a year ago would have delivered you a 68% gainJuly 25, 2024 | marketbeat.comAlimera Sciences, Inc. (NASDAQ:ALIM) Sees Large Increase in Short InterestAlimera Sciences, Inc. (NASDAQ:ALIM - Get Free Report) saw a large growth in short interest during the month of July. As of July 15th, there was short interest totalling 617,100 shares, a growth of 169.1% from the June 30th total of 229,300 shares. Based on an average daily volume of 324,600 shares, the short-interest ratio is presently 1.9 days.July 12, 2024 | marketbeat.comAlimera Sciences, Inc. (NASDAQ:ALIM) Short Interest Up 142.1% in JuneAlimera Sciences, Inc. (NASDAQ:ALIM - Get Free Report) was the target of a significant increase in short interest in June. As of June 30th, there was short interest totalling 229,300 shares, an increase of 142.1% from the June 15th total of 94,700 shares. Based on an average trading volume of 312,200 shares, the short-interest ratio is presently 0.7 days.July 3, 2024 | globenewswire.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc. – ALIMJuly 2, 2024 | prnewswire.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc. - ALIMJune 25, 2024 | marketbeat.comAlimera Sciences' (ALIM) Neutral Rating Reaffirmed at Alliance Global PartnersAlliance Global Partners restated a "neutral" rating on shares of Alimera Sciences in a research report on Tuesday.June 25, 2024 | marketbeat.comAlimera Sciences (NASDAQ:ALIM) Downgraded by HC Wainwright to NeutralHC Wainwright lowered Alimera Sciences from a "buy" rating to a "neutral" rating in a research report on Tuesday.June 24, 2024 | prnewswire.comShareholder Alert: Ademi LLP investigates whether Alimera Sciences, Inc. has obtained a Fair Price for its Public ShareholdersJune 24, 2024 | investorplace.comWhy Is Alimera Sciences (ALIM) Stock Up 77% Today?June 24, 2024 | globenewswire.comALIM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Alimera Sciences to ANI PharmaceuticalsJune 24, 2024 | businesswire.comALIM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Alimera Sciences, Inc. Is Fair to ShareholdersJune 15, 2024 | marketbeat.comAlimera Sciences, Inc. (NASDAQ:ALIM) Sees Significant Growth in Short InterestAlimera Sciences, Inc. (NASDAQ:ALIM - Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 127,000 shares, a growth of 22.2% from the May 15th total of 103,900 shares. Based on an average trading volume of 98,200 shares, the days-to-cover ratio is presently 1.3 days.June 4, 2024 | globenewswire.comAlimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 17, 2024 | marketbeat.comHC Wainwright Research Analysts Cut Earnings Estimates for Alimera Sciences, Inc. (NASDAQ:ALIM)Alimera Sciences, Inc. (NASDAQ:ALIM - Free Report) - Analysts at HC Wainwright decreased their Q3 2024 earnings estimates for Alimera Sciences in a report issued on Thursday, May 16th. HC Wainwright analyst Y. Chen now forecasts that the biopharmaceutical company will post earnings per share of (May 16, 2024 | markets.businessinsider.comRobust Growth and Promising Trials: Buy Rating for Alimera SciencesMay 16, 2024 | marketbeat.comAlimera Sciences (NASDAQ:ALIM) Stock Rating Reaffirmed by HC WainwrightHC Wainwright reissued a "buy" rating and issued a $6.00 price target on shares of Alimera Sciences in a report on Thursday.May 15, 2024 | marketbeat.comAlimera Sciences (NASDAQ:ALIM) Issues Earnings Results, Misses Estimates By $0.08 EPSAlimera Sciences (NASDAQ:ALIM - Get Free Report) released its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($0.08). The business had revenue of $23.01 million during the quarter, compared to analyst estimates of $23.72 million. Alimera Sciences had a negative net margin of 24.93% and a negative return on equity of 130.90%. During the same period in the previous year, the firm posted ($0.71) EPS.May 15, 2024 | finance.yahoo.comAlimera Sciences Inc (ALIM) Q1 2024 Earnings Call Transcript Highlights: Soaring Revenues and ...May 14, 2024 | globenewswire.comAlimera Sciences Reports First Quarter 2024 ResultsMay 7, 2024 | finance.yahoo.comAlimera Announces Scientific Data Highlighting YUTIQ® to be Presented at Upcoming Association for Research in Vision and Ophthalmology and Retina World Congress ConferencesMay 7, 2024 | marketbeat.comAlimera Sciences (ALIM) to Release Earnings on TuesdayAlimera Sciences (NASDAQ:ALIM) will be releasing earnings before the market opens on Tuesday, May 14, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=591841)April 30, 2024 | finance.yahoo.comAlimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate UpdateApril 30, 2024 | marketbeat.comStockNews.com Lowers Alimera Sciences (NASDAQ:ALIM) to HoldStockNews.com cut Alimera Sciences from a "buy" rating to a "hold" rating in a report on Tuesday.April 22, 2024 | marketbeat.comAlimera Sciences (NASDAQ:ALIM) Stock Rating Upgraded by StockNews.comStockNews.com upgraded Alimera Sciences from a "hold" rating to a "buy" rating in a research report on Monday.April 13, 2024 | marketbeat.comAlimera Sciences, Inc. (NASDAQ:ALIM) Sees Large Growth in Short InterestAlimera Sciences, Inc. (NASDAQ:ALIM - Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 108,800 shares, a growth of 26.8% from the March 15th total of 85,800 shares. Based on an average daily volume of 81,900 shares, the days-to-cover ratio is presently 1.3 days.April 12, 2024 | marketbeat.comAlimera Sciences (NASDAQ:ALIM) Downgraded by StockNews.com to "Hold"StockNews.com lowered shares of Alimera Sciences from a "buy" rating to a "hold" rating in a report on Friday.April 4, 2024 | marketbeat.comAlimera Sciences (NASDAQ:ALIM) Lifted to Buy at StockNews.comStockNews.com upgraded shares of Alimera Sciences from a "hold" rating to a "buy" rating in a research note on Thursday.April 3, 2024 | finance.yahoo.comLuckie & Company Acquires Marbury Creative GroupApril 3, 2024 | bizjournals.comLuckie & Co. acquires Atlanta marketing agencyMarch 26, 2024 | finance.yahoo.comOcular Inflammation Treatment Market InsightAce Exclusive Report 2024-2031March 25, 2024 | marketbeat.comAlimera Sciences (NASDAQ:ALIM) Receives New Coverage from Analysts at Maxim GroupMaxim Group assumed coverage on Alimera Sciences in a research report on Monday. They issued a "buy" rating and a $10.00 target price for the company.March 21, 2024 | marketbeat.comAlimera Sciences (NASDAQ:ALIM) Stock Price Crosses Above Two Hundred Day Moving Average of $3.53Alimera Sciences (NASDAQ:ALIM) Stock Crosses Above 200-Day Moving Average of $3.53March 20, 2024 | finance.yahoo.comAlimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 19, 2024 | finanznachrichten.deAlimera Sciences, Inc.: Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina NetworkMarch 19, 2024 | finance.yahoo.comAlimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina NetworkMarch 19, 2024 | globenewswire.comAlimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina NetworkMarch 18, 2024 | msn.comMizuho downgrades Amylyx to Neutral after ALS trial setback Get Alimera Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ALIM and its competitors with MarketBeat's FREE daily newsletter. Email Address Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad)WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race… Click here to see a unique election-year trade ALIM Media Mentions By Week ALIM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALIM News Sentiment▼0.300.55▲Average Medical News Sentiment ALIM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALIM Articles This Week▼11▲ALIM Articles Average Week Get Alimera Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ALIM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DAWN News Today TNGX News Today PRTA News Today GYRE News Today TYRA News Today CGEM News Today COGT News Today XNCR News Today AUTL News Today TARS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALIM) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alimera Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alimera Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.